Sharda Cropchem Ltd Q1 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 7 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹7.1K Cr
Sharda Cropchem Limited expects FY 2026 revenue growth of around 15%. Sharda Cropchem Limited expects revenue growth of around 15% for FY 2026. - EBITDA margin guidance is maintained in the range of 15% to 18%, with a possibility to touch the higher side. - Gross margins are expected to sustain at around 35%-36% for the full year, driven by stable business conditions and favorable forex movements. - PAT grew 424% YoY in Q1 FY26, supported by strong revenue and margin expansion. - The company is investing in registrations and planned CAPEX of Rs.
From Sharda Cropchem Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹761
Market Cap
₹7.1K Cr
P/E Ratio
11.3
How does Sharda Cropchem Ltd rank in Fertilizers & Agrochemicals?
Compare Sharda Cropchem Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
Sharda Cropchem Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹319 Cr.
Full financials →📊 Revenue & Sales Performance
- →Sharda Cropchem Limited expects FY 2026 revenue growth of around 15%.
- →In Q1 FY 2026, revenue grew 25% year-on-year to Rs. 985 crores, with overall volume growth of 13%.
- →Agrochemical segment volume grew 11%, while non-agrochemical segment volume grew 59% year-on-year.
- →The company maintains a robust registration pipeline with over 1,000 product registrations pending approval, supporting future growth.
- →CAPEX planned at Rs. 400-450 crores for the year to support product registrations and expansion.
- →European region, a major contributor, showed strong sales growth of 43% in revenues.
- →Pricing improvements are slow but steady, supporting margin and revenue growth.
- →No major pre-stocking or destocking seen; demand growth is driven by genuine market demand.
- →The management does not foresee disruption in growth due to tariffs or geopolitical issues, maintaining steady business operations.
📈 Profitability & Margins
- →Sharda Cropchem Limited expects revenue growth of around 15% for FY 2026.
- →EBITDA margin guidance is maintained in the range of 15% to 18%, with a possibility to touch the higher side.
- →Gross margins are expected to sustain at around 35%-36% for the full year, driven by stable business conditions and favorable forex movements.
- →PAT grew 424% YoY in Q1 FY26, supported by strong revenue and margin expansion.
- →The company is investing in registrations and planned CAPEX of Rs. 400-450 crores to support future growth.
- →No adverse inventory impacts or order cancellations anticipated, implying business stability.
- →Currency exchange benefits, especially from Euro appreciation, are contributing positively.
- →Management is optimistic about steady price improvements and strong demand on the ground rather than inventory restocking.
- →With strong cash reserves and disciplined working capital management, the company is well-positioned for sustained profitability growth.
🏗️ Capital Expenditure Plans
💰 Fundraising & Capital Structure
- →There is no explicit mention of any current or planned fundraising through debt or equity in the document.
- →The company remains debt-free as of June 30, 2025, with a strong cash and liquid investment position of Rs. 791 crores.
- →Management emphasizes maintaining a comfortable cash position to manage adverse situations and support business continuity.
- →CAPEX planned for FY 2026 is Rs. 400-Rs. 450 crores, funded internally from cash resources.
- →There is no indication of raising fresh debt or equity in the near term.
- →The focus appears to be on organic growth and prudent cash management without additional fundraising.
📋 Order Book & Pipeline
- →As of 30th June 2025, Sharda Cropchem has 2,981 registrations.
- →Additionally, there are 1,021 applications for product registrations at the approval stage.
- →There was no specific mention of the current or expected order book value or pending orders in the Q1 FY26 earnings call transcript.
- →The company indicated strong registration pipeline and continued pursuit of registrations once initiated, unless regulatory bans occur.
- →The management did not elaborate quantitatively on pending orders or order backlog during the call.
Key Metrics
Frequently Asked Questions
What were Sharda Cropchem Ltd Q1 FY26 results?
Sharda Cropchem Limited expects FY 2026 revenue growth of around 15%. Sharda Cropchem Limited expects revenue growth of around 15% for FY 2026. - EBITDA margin guidance is maintained in the range of 15% to 18%, with a possibility to touch the higher side. - Gross margins are expected to sustain at around 35%-36% for the full year, driven by stable business conditions and favorable forex movements. - PAT grew 424% YoY in Q1 FY26, supported by strong revenue and margin expansion. - The company is investing in registrations and planned CAPEX of Rs.
What is Sharda Cropchem Ltd share price analysis?
Sharda Cropchem Ltd currently shows a neutral. The stock trades at a P/E of 11.3 with a market cap of ₹7,095 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sharda Cropchem Ltd planning capital expenditure?
CAPEX for Q1 FY26 stood at Rs.
Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.